Processing

Please wait...

Settings

Settings

Goto Application

1. MXMX/a/2007/011211 - FUSED THIAZOLE DERIVATIVES HAVING AFFINITY FOR THE HISTAMINE H3 RECEPTOR

Office Mexico
Application Number MX/a/2007/011211
Application Date 13.09.2007
Publication Number MX/a/2007/011211
Publication Date 15.02.2008
Publication Kind A
IPC
A61K 31/55
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
55having seven-membered rings, e.g. azelastine, pentylenetetrazole
A61P 25/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25Drugs for disorders of the nervous system
C07D 513/04
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
513Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/, C07D477/232
02in which the condensed system contains two hetero rings
04Ortho-condensed systems
Applicants GLAXO GROUP LIMITED
Inventors WILSON, David Matthew
BAILEY, Nicholas
PICKERING, Paula Louise
Agents HERIBERTO RAUL LOPEZ PADILLA.*
Priority Data 0505205.5 14.03.2005 GB
0525239.0 12.12.2005 GB
Title
(EN) FUSED THIAZOLE DERIVATIVES HAVING AFFINITY FOR THE HISTAMINE H3 RECEPTOR
(ES) DERIVADOS DE TIAZOL FUSIONADO QUE TIENEN AFINIDAD PARA EL RECEPTOR H3 DE HISTAMINA
Abstract
(EN)
The present invention relates to novel fused thiazole derivatives having pharmacological activity, processes for their preparation, to compositions containing them and to their use in the treatment ofneurological and psychiatric disorders.

(ES)
La presente invención se refiere a derivados de tiazol fusionado novedosos que tienen actividad farmacológica, procedimientos para su preparación, a composiciones que los contienen y a su uso en el tratamiento de trastornos neurológicos y psiquiátricos.